Working to Eradicate Gynecologic Cancers

46 - Featured Poster
Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced-stage serous ovarian or primary peritoneal cancer: a Gynecologic Oncology Group (GOG) study

Sunday, March 23, 2014: 6:45 AM
Room 13-16 (Tampa Convention Center)
T. C. Krivak1, D. Tritchler2, K. N. Moore3, K. Kaufman4, H. Lankes2, D. K. Armstrong5, M. J. Birrer6, M. F. Brady7 and M. A. Bookman8
1Western Pennsylvania Hospital, Pittsburgh, PA, 2Gynecologic Oncology Group Statistical and Data Center, Buffalo, NY, 3The University of Oklahoma, Oklahoma City, OK, 4University of Oklahoma, Oklahoma City, OK, 5Johns Hopkins Kimmel Cancer Center, Baltimore, MD, 6Massachusetts General Hospital Cancer Center/Harvard University, Boston, MA, 7University of Buffalo, Buffalo, NY, 8University of Arizona Cancer Center, Tucson, AZ
 
See more of: Featured Poster Session II: Predictors of Outcomes in Ovarian Cancer/Translational Science
See more of: Featured Poster Session
<< Previous Presentation | Next Presentation >>